Acumen Pharmaceuticals Inc (ABOS) stock has fallen -71.39% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ABOS stock a score of 26 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 3. ABOS's rank also includes a short-term technical score of 6.
ABOS has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on ABOS!
Acumen Pharmaceuticals Inc (ABOS) stock is down -10.43% while the S&P 500 has risen 0.3% as of 12:51 PM on Tuesday, Oct 31. ABOS has fallen -$0.23 from the previous closing price of $2.21 on volume of 991,464 shares. Over the past year the S&P 500 has gained 7.93% while ABOS has fallen -71.39%. ABOS lost -$1.14 per share in the over the last 12 months.
Click Here to get the full Stock Report for Acumen Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
